Departmental Affiliations
Primary
Contact Info
624 N. Broadway Room 763, Baltimore, MD, , USA
Baltimore
Maryland
21205
US
Research Interests
Psychiatric epidemiology; Substance use disorder; Drug overdose; Data harmonization; Secondary data analysis; Systematic review; Integrative individual-level meta-analysis
Experiences & Accomplishments
Education
MPH
Tehran University of Medical Sciences
2008
MD
Hamedan University of Medical Sciences
1997
Overview
Dr. Masoumeh Amin-Esmaeili is a psychiatric epidemiologist with extensive experience in clinical practice as a psychiatrist. Her research has focused on three related areas: 1) systematic review of evidence regarding psychiatric disorders, substance use and its harms including blood-borne infection; 2) conducting primary research studies in the mental health and substance abuse epidemiology; and 3) initiatives aimed at implementing findings from behavioral health research in health services.
Honors & Awards
Pilot project research training awards, The New Johns Hopkins POE Total Worker Health Center in Mental Health, USA (2022-2023)
Samuel Gershon award and GSK travel fellowship award for junior researchers, the third biennial conference on Bipolar Disorders, India (2008)
Samuel Gershon award and GSK travel fellowship award for junior researchers, the third biennial conference on Bipolar Disorders, India (2008)
Select Publications
The most recent publications:
- Amin-Esmaeili, M., Alinsky, R., Johnson, R. M., Gribble, A., Oyedele, N., Parnham, T., . . . Susukida, R. (2023). Impact of unsolicited reporting notifications on providers' prescribing behavior: An experimental study on Maryland PDMP data. Drug and Alcohol Dependence, 248, 109896. doi:10.1016/j.drugalcdep.2023.109896
- Mojtabai, R., & Amin-Esmaeili, M. (2022). Validity of self-reports of medication treatment of depression in general population surveys. Pharmacoepidemiology and Drug Safety, 31(4), 461-466. doi:https://doi.org/10.1002/pds.5400
- Mojtabai, R., Amin-Esmaeili, M., Spivak, S., & Olfson, M. (2023). Use of Non-Psychiatric Medications With Potential Depressive Symptom Side Effects and Level of Depressive Symptoms in Major Depressive Disorder. The Journal of Clinical Psychiatry, 84(4), 47188.
- Amin-Esmaeili, M., Gribble, A., Johnson, R. M., Alinsky, R. H., Oyedele, N., Parnham, T., . . . Susukida, R. (2022). Unsolicited reporting notifications (URNs) through Maryland's prescription drug monitoring program (PDMP): Characteristics of providers. Drug and Alcohol Dependence Reports, 5, 100111. doi:https://doi.org/10.1016/j.dadr.2022.100111
- Gholami, J., Baheshmat, S., Rostam-Abadi, Y., Hamzehzadeh, M., Mojtabai, R., Rahimi-Movaghar, A., & Amin-Esmaeili, M. (2022). Mortality and negative outcomes of opioid use and opioid use disorder: a 6-year follow-up study. Addiction, 117(7), 2059-2066. doi:10.1111/add.15805